Thyroid Cancer
摘要
18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography is used in various clinical settings for thyroid cancers, and the role of non-FDG PET tracers in thyroid cancer is evolving. This chapter will answer common questions about FDG PET and non-FDG PET tracers and their clinical applications, advantages, and limitations in thyroid cancer.